Gene Query: PYM1

Dataset Description Geneva Score
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 16.35
Genome wide expression change by RNF168 knocking down in MCF-7 cells 15.96
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 15.24
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 13.47
Seletive inhibition of CDK9 in DLBCL cell lines 11.98
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 11.1
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 9.57
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 9.57
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 9.21
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 8.64
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 8.47
NR2F2 study 8.47
Transcriptome analysis of SKI knock-out in HL60 cells 8.32
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 8.32
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 8.29
The evolution of N6-methyladenosine in primates 8.09
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 8.03
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 7.87
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 7.83
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 7.26
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 7.11
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 7.11
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 6.69
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 6.69
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 6.66
scRNASeq analysis of cycling cardiomyocytes 6.65
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 6.57
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 6.49
Targeting MTHFD2 in Acute Myeloid Leukemia 6.47
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 6.43
Transcriptome-wide identification of CELF2 functional targets in T cells 6.42
Comprehensive comparative analysis of 5’ end RNA sequencing methods 6.2
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 6.14
Total RNA sequencing of WT intestinal orgaonids. 6.09
CROP-Seq in Primary Human T Cells 6.04
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 6.03
MeRIP-seq for heat shock in B-cell lymphoma cells 5.88
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 5.78
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 5.64
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 5.55
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 5.38
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 5.38
Generating Patterned Kidney Organoids for Studying Development and Diseases 5.24
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 5.2
Differentially expressed genes post knock down of lincDUSP26 5.12
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 5.11
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 5.1
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 4.99
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 4.95
DART-seq: an antibody-free method for global m6A detection 4.9
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 4.9
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 4.86
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 4.82
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 4.8
ARS2 is a general suppressor of pervasive transcription [RNAseq] 4.74
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 4.73
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 4.72
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 4.66
Effect of drugs on transcriptomic profiles 4.65
Integrating single-cell transcriptomic data across different conditions, technologies, and species 4.63
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 4.56
Characterization of parental and rociletinib-resistant derived H1975 cell lines 4.54
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 4.54
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 4.52
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 4.48
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 4.47
Global analysis of enhancer targets: Mosaic-seq 4.34
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 4.32
Developmental stage specific chromosome architecture in human erythroid cells 4.32
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 4.32
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 4.27
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 4.26
BAF controls genome accessibility 4.24
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 4.23
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 4.23
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 4.21
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 4.13
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 4.04
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 4.04
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 4.0
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 3.99
Accurate annotation of human protein-coding small open reading frames 3.96
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 3.95
Effect of CHKA knockdown on C4-2 cell transcriptome 3.95
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 3.94
Mechanistic Model-Guided Study of Embryonic Morphogenesis 3.94
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 3.93
RNA-seq differential expression studies: more sequence, or more replication? 3.92
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 3.89
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 3.85
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 3.85
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 3.82
The role of FAM46C in myeloma cells 3.81
The role of FAM46C in myeloma cells [sequencing] 3.81
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 3.79
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 3.79
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 3.78
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.75
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 3.72
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 3.7
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 3.67
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 3.66
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 3.66
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 3.65
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 3.64
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 3.59
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 3.58
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 3.58
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 3.53
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 3.53
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 3.52
Identification of renal resident macrophages across species 3.5
A Unique Epigenomic Landscape Defines Human Erythropoiesis 3.5
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 3.5
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 3.48
A novel target of EZH1/2 for treatment of mantle cell lymphoma 3.47
T47D RNA-seq and ChrRNA-seq data 3.46
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 3.46
Differentially expressed vascular development genes for iPSC-ECs from CDI 3.41
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 3.41
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 3.4
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 3.39
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 3.39
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 3.39
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 3.38
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 3.35
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 3.32
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 3.26
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 3.18
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 3.18
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 3.18
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 3.17
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 3.15
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 3.15
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 3.1
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 3.08
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 3.08
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 3.08
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 3.08
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 3.06
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 3.05
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 3.03
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 3.03
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 3.01
hTERT promotes cell adhesion and migration independent of telomerase activity 3.01
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 2.97
Role for citron kinase in prostate cancer growth 2.96
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 2.93
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 2.92
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 2.92
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 2.92
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.9
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 2.85
Next Generation Sequencing of human SMA and healthy control Motor Neurons 2.84
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 2.83
RNA seq analysis of human Fetal and adult derived Enterospheres 2.82
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 2.8
Transcriptome analysis of H9 hESC derived cerebral organoids 2.79
Impact of dieldrin on transcription in Jurkat T cells 2.77
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 2.76
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 2.74
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 2.74
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 2.74
Identification of Nrf2 regulated genes by RNA sequencing 2.74
Nrf2 regulated genes in A549 cells 2.74
NRDE2 negatively regulates nuclear exosome functions 2.74
RNA-seq analysis of RALD iPSCs after in vitro differentiation 2.73
RNAseq Study in CC-671 Treated Cal-51 Cells 2.72
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 2.68
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 2.68
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 2.67
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 2.65
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 2.65
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 2.63
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 2.63
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 2.62
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 2.61
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 2.61
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 2.6
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 2.58
Transcriptional changes in lymphoma cells induced by LSD1 depletion 2.58
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 2.58
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 2.56
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 2.56
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 2.55
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 2.55
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 2.54
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 2.53
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 2.53
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 2.51
Genome wide expression change by RNF168 knocking down in NEC cells 2.5
The comparison of high-throughput single-cell RNA-seq methods 2.5
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 2.49
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 2.47
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 2.45
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 2.45
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 2.45
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 2.44
U1 snRNP telescripting regulates size-function stratified human genome 2.44
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 2.42
Paxillin regulates genomic networks in prostate cancer [C4-2] 2.42
Genome-wide functional assessment of enhancer activities in the human genome 2.41
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 2.41
Trans-differentiation of human adult peripheral blood T cells into neurons 2.4
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.39
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 2.39
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 2.39
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 2.36
Gene expression changes associated with resistance to tagraxofusp (SL-401) 2.36
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 2.35
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 2.34
Human Treg IL-12 stimulation 2.33
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 2.32
Uridylation by TUT4 and TUT7 marks mRNA for degradation 2.32
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 2.32
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 2.32
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 2.3
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 2.3
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 2.3
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 2.29
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 2.29
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 2.28
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 2.28
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 2.27
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 2.26
SRSF2 mutations impair hematopoiesis and alter exon recognition 2.26
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 2.24
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 2.24
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 2.23
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 2.23
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 2.22
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 2.22
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 2.22
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 2.19
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 2.18
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 2.16
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 2.15
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 2.13
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 2.11
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 2.07
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 2.05
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 2.03
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 2.01
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 2.0
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 1.99
Transcriptional profiling of microglia; current state of the art and future perspectives 1.98
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 1.98
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 1.97
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 1.97
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 1.95
Human Treg NaCl stimulation 1.95
Functional role of SLIT2 and ROBO1 in trophoblasts 1.94
Selective expression of long non-coding RNAs in a breast cancer cell progression model 1.94
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 1.93
Characterization of human ILC2 subsets 1.93
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 1.93
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 1.93
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 1.93
Genome-wide analysis of the Integrator complex (HTS) 1.93
Genome-wide analysis of the Integrator complex 1.93
Genetic-to-epigenetic Therapy for Pancreatic Cancer 1.91
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 1.9
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 1.88
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 1.88
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 1.87
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.86
Identification of global XBP1s target gene expression in human prostate cancer cells 1.84
Iron response of HepG2 cells 1.82
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 1.82
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 1.79
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 1.77
Regulating Interleukin-2 activity with engineered receptor signaling clamps 1.74
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 1.73
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 1.72
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 1.72
Identification of HOXB13 target genes responsive to BET inhibitors 1.7
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 1.7
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 1.69
RNA-seq of naive and primed ES cells 1.69
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 1.69
Gene expression signatures of innate lymphoid cells from human blood 1.68
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 1.68
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.66
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 1.64
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 1.61
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 1.61
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 1.59
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 1.59
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 1.58
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 1.58
The transcriptome effect of overexpressing EZH2 in MCF7 1.55
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.54
Transcriptional effect of ETV1 knockdown in melanoma cells 1.54
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 1.53
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 1.53
Generation and persistence of human tissue-resident memory T cells in lung transplantation 1.53
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 1.53
High-throughput sequencing of pluripotent cells 1.52
RNA-Seq of PRMT1 overexpression ECA109 cells 1.52
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 1.52
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 1.51
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.46
miRNAs affected by antagomiR-17 treatment 1.46
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 1.44
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 1.44
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.44
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 1.43
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 1.4
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 1.33
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 1.32
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 1.32
LIN28A modulates splicing and gene expression programs in breast cancer cells 1.32
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.32
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 1.32
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 1.31
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.31
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 1.31
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.31
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.31
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 1.29
Expression and functions of long noncoding RNAs during human T helper cell differentiation 1.27
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 1.24
RNA-seq analysis upon ARID1B overexpression 1.24
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 1.21
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 1.21
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 1.21
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 1.21
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 1.21
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.21
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 1.2
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.2
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 1.18
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.17
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.16
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 1.16
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 1.16
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 1.15
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 1.14
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 1.13
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 1.09
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 1.07
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 1.06
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 1.05
CDK4/6 inhibitor resistance in prostate cancer 1.05
RNA editing in nascent RNA affects pre-mRNA splicing 1.03
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 1.03
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.03
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.03
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 1.02
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.01
RNA-Seq from human ILC transitional populations 1.0
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 1.0
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 0.97
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 0.96
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 0.96
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 0.95
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 0.95
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 0.94
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 0.94
Hepatitis C virus functionally sequesters miR-122 0.94
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.93
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.92
A single cell reference map for human blood and tissue T cell activation 0.92
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 0.91
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 0.91
Effect of PBK knockdown on C4-2 cell transcriptome 0.91
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 0.91
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 0.91
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.9
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 0.89
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.88
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.88
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.87
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.86
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 0.86
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 0.84
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.84
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 0.84
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 0.83
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.82
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.8
Loss of CREBBP results in gene expression repression in lymphoma cells 0.8
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 0.8
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.79
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 0.79
Expression profiling of MCF-7 cells with treatment of TCDD 0.79
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 0.76
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 0.76
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.76
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.76
Impact on erythroid progenitor type on erythroid differntiation 0.73
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 0.73
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 0.72
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 0.72
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.71
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.66
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 0.66
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.66
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.66
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 0.65
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 0.65
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 0.65
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 0.64
quanTIseq: quantifying immune contexture of human tumors 0.61
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 0.61
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 0.6
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.58
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.58
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.56
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.56
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.55
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.54
Primate transcript and protein expression levels evolve under compensatory selection pressures 0.53
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 0.53
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 0.53
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.53
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 0.52
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.52
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.51
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 0.5
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 0.5
RNAseq of cell lines with knocked in ESR1 mutations 0.48
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 0.45
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 0.44
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.44
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.44
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 0.41
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.41
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.4
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 0.4
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.39
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.37
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.36
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.36
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.35
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 0.35
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.35
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.35
Role of FGFR1 in neuronal devlopment 0.35
Tracing Enhancer Networks using Epigenetic Traits (TENET) 0.34
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.34
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 0.34
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.33
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.33
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.33
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 0.33
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.3
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.3
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.29
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 0.29
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 0.29
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 0.29
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.26
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.26
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.25
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.25
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.25
JAK dependent survival of ALK- ALCL 0.24
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.23
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.23
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 0.22
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 0.21
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 0.21
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.21
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 0.2
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 0.2
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.18
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.18
The circadian transcriptional landscape in primary human mammary epithelial cells 0.18
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.18
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 0.17
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 0.16
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.16
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.16
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.14
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 0.14
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.14
Cellular response to hepatitis E virus (HEV) infection 0.1
Effect of nuclear IL-33 on gene expression 0.09
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.09
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.08
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.08
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.08
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 0.08
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 0.08
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 0.07
Global transcriptome analysis of WT versus HEB-/- hESCs 0.07
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 0.07
Functional Haploid Human Oocytes Generated from Polar Body Genomes 0.07
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 0.06
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.06
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.06
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.06
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.05
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 0.05
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.04
Oncogenic roles of ARID5B in T-ALL 0.04
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.04
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.03
Transcriptome-wide modulation of splicing by the exon junction complex 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation